These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 17116676)

  • 1. High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
    Baniecki ML; Wirth DF; Clardy J
    Antimicrob Agents Chemother; 2007 Feb; 51(2):716-23. PubMed ID: 17116676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Novel High-Density [3H]Hypoxanthine Scintillation Proximity Assay To Assess Plasmodium falciparum Growth.
    de Cózar C; Caballero I; Colmenarejo G; Sanz LM; Álvarez-Ruiz E; Gamo FJ; Cid C
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5949-56. PubMed ID: 27458216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.
    Johnson JD; Dennull RA; Gerena L; Lopez-Sanchez M; Roncal NE; Waters NC
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1926-33. PubMed ID: 17371812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
    Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
    Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.
    Linares M; Viera S; Crespo B; Franco V; Gómez-Lorenzo MG; Jiménez-Díaz MB; Angulo-Barturen Í; Sanz LM; Gamo FJ
    Malar J; 2015 Nov; 14():441. PubMed ID: 26542470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for new antimalarial therapeutics amongst known drugs.
    Weisman JL; Liou AP; Shelat AA; Cohen FE; Guy RK; DeRisi JL
    Chem Biol Drug Des; 2006 Jun; 67(6):409-16. PubMed ID: 16882315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.
    Sharma V; Agarwal S; Madurkar SM; Datta G; Dangi P; Dandugudumula R; Sen S; Singh S
    Malar J; 2014 Nov; 13():467. PubMed ID: 25431142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes.
    Peatey CL; Spicer TP; Hodder PS; Trenholme KR; Gardiner DL
    Mol Biochem Parasitol; 2011 Dec; 180(2):127-31. PubMed ID: 21939693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning: the fast track to new anti-malarial medicines?
    Lotharius J; Gamo-Benito FJ; Angulo-Barturen I; Clark J; Connelly M; Ferrer-Bazaga S; Parkinson T; Viswanath P; Bandodkar B; Rautela N; Bharath S; Duffy S; Avery VM; Möhrle JJ; Guy RK; Wells T
    Malar J; 2014 Apr; 13():143. PubMed ID: 24731288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-cell in vitro screening for gametocytocidal compounds.
    Lucantoni L; Avery V
    Future Med Chem; 2012 Dec; 4(18):2337-60. PubMed ID: 23234555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
    Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
    Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90.
    Shahinas D; Liang M; Datti A; Pillai DR
    J Med Chem; 2010 May; 53(9):3552-7. PubMed ID: 20349996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Cell Phenotypic Screening of Medicines for Malaria Venture Pathogen Box Identifies Specific Inhibitors of
    Patra AT; Hingamire T; Belekar MA; Xiong A; Subramanian G; Bozdech Z; Preiser P; Shanmugam D; Chandramohanadas R
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes.
    Vos MW; Stone WJ; Koolen KM; van Gemert GJ; van Schaijk B; Leroy D; Sauerwein RW; Bousema T; Dechering KJ
    Sci Rep; 2015 Dec; 5():18704. PubMed ID: 26687564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
    Lucumi E; Darling C; Jo H; Napper AD; Chandramohanadas R; Fisher N; Shone AE; Jing H; Ward SA; Biagini GA; DeGrado WF; Diamond SL; Greenbaum DC
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3597-604. PubMed ID: 20547797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.